These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 16818683)

  • 1. Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer.
    Ferris RL; Whiteside TL; Ferrone S
    Clin Cancer Res; 2006 Jul; 12(13):3890-5. PubMed ID: 16818683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
    Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
    Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
    Andratschke M; Pauli C; Stein M; Chaubal S; Wollenberg B
    Anticancer Res; 2003; 23(2B):1467-71. PubMed ID: 12820411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.
    Ferris RL; Hunt JL; Ferrone S
    Immunol Res; 2005; 33(2):113-33. PubMed ID: 16234579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
    Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
    Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.
    Raffaghello L; Nozza P; Morandi F; Camoriano M; Wang X; Garrè ML; Cama A; Basso G; Ferrone S; Gambini C; Pistoia V
    Cancer Res; 2007 Jun; 67(11):5471-8. PubMed ID: 17545629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL.
    López-Albaitero A; Nayak JV; Ogino T; Machandia A; Gooding W; DeLeo AB; Ferrone S; Ferris RL
    J Immunol; 2006 Mar; 176(6):3402-9. PubMed ID: 16517708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.
    Weinman EC; Roche PC; Kasperbauer JL; Cha SS; Sargent DJ; Cheville J; Murphy LM; Chen L; Wettstein PJ; Gostout B; Ferrone S; Strome SE
    Cancer; 2003 May; 97(9):2203-11. PubMed ID: 12712472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?
    Chang CC; Campoli M; Ferrone S
    Curr Opin Immunol; 2004 Oct; 16(5):644-50. PubMed ID: 15342012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class I antigens, immune surveillance, and tumor immune escape.
    Garcia-Lora A; Algarra I; Garrido F
    J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
    Rouas-Freiss N; Moreau P; Ferrone S; Carosella ED
    Cancer Res; 2005 Nov; 65(22):10139-44. PubMed ID: 16287995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
    J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of surface HLA class I levels in squamous cell carcinoma cell lines of the head and neck.
    Mandic R; Lieder A; Sadowski M; Peldszus R; Werner JA
    Anticancer Res; 2004; 24(2B):973-9. PubMed ID: 15161052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M; Whiteside TL; Kaufmann R; Seliger B
    Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
    Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
    J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High level of aneuploidy of chromosome 6 by FISH analysis of head and neck squamous cell carcinoma: limited applicability of LOH analysis to define HLA loss.
    Koene GJ; Arts-Hilkes YH; van Dijk AJ; van der Ven KJ; Slootweg PJ; de Weger RA; Tilanus MG
    Hum Immunol; 2004 Dec; 65(12):1455-62. PubMed ID: 15603873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class I antigens and immune surveillance in transformed cells.
    Aptsiauri N; Cabrera T; Garcia-Lora A; Lopez-Nevot MA; Ruiz-Cabello F; Garrido F
    Int Rev Cytol; 2007; 256():139-89. PubMed ID: 17241907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer.
    So T; Takenoyama M; Mizukami M; Ichiki Y; Sugaya M; Hanagiri T; Sugio K; Yasumoto K
    Cancer Res; 2005 Jul; 65(13):5945-52. PubMed ID: 15994973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells.
    Concha-Benavente F; Srivastava R; Ferrone S; Ferris RL
    Oral Oncol; 2016 Jul; 58():52-8. PubMed ID: 27264839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.